US company Dexcom has announced plans to build its newest manufacturing facility in Athenry, creating around 1,500 jobs.
Dexcom Inc. expects to create roughly 500 construction jobs while the facility is being built, and up to 1,000 high-tech positions once the site is up and running.
The multinational is a global leader in glucose monitoring for people with diabetes.
An Taoiseach Leo Varadkar congratulated Dexcom on the move, saying it is great news for local employment and the local economy in Galway and the wider region.
The project is being supported by the Government through IDA Ireland, and represents an investment of €300 million over five years.
“I was pleased to meet with Dexcom this time last year when I visited their headquarters in San Diego. This will be one of the biggest single private sector investments ever in the West of Ireland,” said An Taoiseach.
“In addition to the thousand jobs being created by the company, it will bring many spin-off opportunities, jobs and contracts for other businesses in the region.”
Subject to planning permission, the Ireland site will be Dexcom’s first manufacturing site in Europe, expanding upon the company’s existing capabilities in the U.S. and Malaysia.
Barry Regan, Executive Vice President of Global Operations at Dexcom, said: “With the continued success of our Dexcom G7 in Europe, we are pursuing an ambitious growth strategy that requires increased manufacturing capacity to support our rapidly expanding European user base.”
“Ireland has an exceptional talent pool and an established MedTech sector, making Athenry the perfect location for us to establish a new, state-of-the-art manufacturing facility.”
